4Giraudo E, primo 1., Audero E, et al. Tumor necrosis factor-a regulates expression of vascular endothelial growth factor receptor -2 and of its coreceptor neuropilin-1 human vascular endothelial Cells[J]. J Biol Chem, 1998, 272(34) : 22128 - 22135.
5Cordingley FT, Bianchi A, Hoffbrand AV, et al. Tumour necrosis factor as anautocrinc tumour growh factor for chronic B - cell nmligmancics[J]. Lancet, 1988, 1(8592) : 969- 971.
6Strieter RM, Chensue SW, Basha MA, et al. Human alevolar nmcrophage gene expression of interleukin-8 by tumomecrosis facter, alipolysaccharide and interleukin-1 [J]. Am J Respir Cell Mol Biol, 1990, 2(4): 321-326.
7Robin LA, Neson DL. The Soluble interleukin - 2 receptor biology,function, and clinical application [J]. Ann Inter Med, 1990, 113 (8) :619 - 627.
5Robert C, Martin M, Samuel R, et al. Evaluation of intraoperative autotransfusion filtration for hepateetowy and pancreatecton[J] . Aun Surg Oncol 2005,12(11) : 1017-1024.
6Hart OJj,Klimberg Iw,Wajsman Z,et al. Intraoperative autotransfusion in radical eystectomy for carcinoma of the bladde[J]. Surg Gynecal obstet, 1989,168(4) :302.
7Hill I, James V. Survey of autologous blood transfusion ac- tivity in England ( 2001 ) [ J ]. Transfus Med, 2003,13 (1) :9-15.
8Shir A, Michal A, Ariella G, et al. Blood transufusion pro- mates cancer progression:a critical role for aged erytbro-cytes [ J ]. Anesthesiol, 2008,109 (6) :989-997.
9Kbs M, Korsak J. Immunomodulatory effect of blood components transfusions [ J ]. PoM erkuriusz Lek ,2002 ,13 (77) :4131.
10Hensler T, tteinemann B, Sauerland S, et al. Immunologic altera- tions associated with high blood transfusion volume after multiple injury:effects on plasmatic cytokine and cytokine receptor concen- trations [ J ]. Shock,2003,20:497 - 502.
